Immune‐mediated necrotizing myopathy after BNT162b2 vaccination in a patient with antibodies against receptor‐binding domain of SARS‐CoV ‐2 and signal recognition particle-Reference-Cited by-同舟云学术

Immune‐mediated necrotizing myopathy after BNT162b2 vaccination in a patient with antibodies against receptor‐binding domain of SARS‐CoV ‐2 and signal recognition particle

Published:2022-01-19 Issue: Volume: Page:
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Dodig Dubravka¹,Fritzler Marvin J.²,Naraghi Ali³,Tarnopolsky Mark A.⁴⁵,Lu Jian‐Qiang⁶^ORCID

Affiliation:

1. Division of Neurology University Health Network, Toronto Western Hospital Toronto Ontario Canada

2. Department of Medicine Cumming School of Medicine, University of Calgary Calgary Alberta Canada

3. Division of Musculoskeletal Radiology, Toronto Joint Department of Medical Imaging University Health Network, Mount Sinai Hospital and Women’'s College Hospital Toronto Ontario Canada

4. Department of Medicine/Neurology McMaster University Hamilton Ontario Canada

5. Department of Pediatrics McMaster University Hamilton Ontario Canada

6. Department of Pathology and Molecular Medicine McMaster University Hamilton Ontario Canada

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27483

Reference7 articles.

1. Surveillance for adverse events after COVID‐19 mRNA vaccination;Klein NP;JAMA,2021

2. How to report the antinuclear antibodies (anti‐cell antibodies) test on HEp‐2 cells: guidelines from the ICAP initiative;Mühlen CA;Immunol Res.,2021